Eyenovia Provides Manufacturing Update and Announces

NEW YORK, July 18, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of late-stage microdose array print (MAP™) therapeutics, provided an update on its expanded manufacturing capabilities today and also announced the appointment of Bren Kern as Senior Vice President of Manufacturing and Operations. Redwood City, CA …

Eyenovia Provides Manufacturing Update and Announces Read More »